Introduction
Sleep is an essential process that is highly conserved across evolution, yet its functions and underlying mechanisms of control are poorly understood. One of the most conserved features of sleep is its association with large-scale changes in brain activity relative to the waking state, suggesting that modulation of neuronal activity may be central to the regulation of sleep. In support of this hypothesis, homologous genes in mammals and flies encoding ion channels and ionotropic receptors have been shown to be necessary for normal sleep [1] [2] [3] [4] . The requirement for potassium (K) channels in the Shaker (Sh) family is particularly notable. In both mammals and flies, loss-of-function mutations in Sh or its orthologs cause reduced sleep [2, 4] . Although little is known about whether modulators of Sh-type channels might control sleep in mammals, loss-of-function mutations in either of two genes that upregulate Sh, hyperkinetic (Hk) and quiver/sleepless (qvr/sss), result in reduced sleep in flies [5] [6] [7] . Unlike Hk, which is a cytosolic protein, SSS is anchored by glycosylphosphatidylinositol (GPI) to the outer leaflet of the plasma membrane, where it may associate with the extracellular surfaces of other membrane proteins. Evidence suggests that one such protein is Sh itself. For example, SSS and Sh are expressed in many of the same regions of the fly brain, SSS can form a stable complex with and upregulate levels of Sh protein, and SSS can increase the activation kinetics and decrease C-type inactivation kinetics of Sh channels in excised patches of transfected cells [6] [7] [8] .
However, differences between the sleep phenotypes of Sh and qvr/sss mutants suggest that the two genes may not act in exactly the same signaling pathways. For example, over several generations, selection pressure appears to favor the accumulation of genetic modifiers in populations of Sh mutants to compensate for loss of sleep [4] . In contrast, loss of sleep in qvr/sss-null mutants is not lost over the same time span, if at all (unpublished data), signifying that the qvr/sss phenotype cannot be easily overcome by other naturally occurring alleles in the genome. Furthermore, although Sh mutants exhibit homeostatic recovery sleep after periods of sleep deprivation [4] , this process is impaired in qvr/sss mutants [6] . Collectively, these differences suggest that SSS may have other downstream effectors that, in combination with Sh, control sleep.
Clues about the identities of such effectors may be gleaned from the predicted structure of SSS. Modeling of the tertiary structure reveals that SSS is a member of a large family of proteins, including snake a-neurotoxins, which possess a ''threefinger'' fold that has also been referred to as the ly6 domain [7] . Intriguingly, many of the targets of a-neurotoxins have been identified as ion channels or acetylcholine signaling pathways. For example, FS-2 blocks voltage-gated Ca channels [9] , fasciculin-I blocks acetylcholinesterase [10] , MT2 acts on muscarinic acetylcholine receptors [11] , and a-bungarotoxin inhibits nicotinic acetylcholine receptors (nAChRs) [12] . Although ly6-domain-encoding homologs of qvr/sss have also been identified in the genomes of nonvenomous animals [13, 14] , in most cases the endogenous binding partners of the corresponding proteins have not been identified.
In mammals, however, evidence strongly suggests that two of these proteins, lynx1 and lynx2, are endogenous antagonists of nAChRs. For example, lynx1 and lynx2 can complex with and accelerate the desensitization rates of a4b2 nAChRs [15, 16] . Consistent with these effects, lynx1-knockout mice have extended critical periods for ocular dominance plasticity that requires nAChR activity [17] , and lynx2-knockout mice have increased nicotine-evoked excitatory postsynaptic potentials in prefrontal cortical pyramidal neurons [18] .
As a result of such studies, we hypothesized that the ly6-domain-containing protein SSS may also antagonize nAChRs to reduce synaptic transmission. Here we present evidence *Correspondence: wjoiner@ucsd.edu Figure 1 . sss Neurons Promote Waking and Are Sensitive to Pharmacological Inhibition of nAChRs and K channels (A) sss neurons are sufficient for waking. sss-Gal4>UAS-TRPA1, UAS-TRPA1>+ and sss-Gal4>+ animals were heat pulsed to 27 C from ZT18-ZT24 from a baseline temperature of 22 C. Change in sleep was calculated as sleep during the heat pulse minus sleep over the equivalent time period 24 hr before. n > 13 animals for each group.
(legend continued on next page)
to support this hypothesis and demonstrate that the resulting receptor inhibition is required for normal sleep in Drosophila. Specifically, we show that pharmacological or genetic reduction of nAChR signaling restores sleep to qvr/sss mutants. We also show that SSS regulates nAChRs posttranscriptionally, most likely by direct inhibition, since SSS coimmunoprecipitates with the fly nAChR Da3 and inhibits nAChR activity in transfected cells. Finally, we show that the mammalian SSS homolog lynx1 restores sleep to qvr/sss mutants and coimmunoprecipitates with a murine homolog of Sh, Kv1.2. Collectively, our data suggest the existence of an evolutionarily conserved, dual role for SSS-like molecules in reducing excitability and synaptic transmission to control essential nervous system functions like sleep.
Results

SSS-Expressing Neurons Are Required for Waking
We previously demonstrated that loss-of-function mutations in qvr/sss or Sh lead to increased miniature excitatory postsynaptic potential frequency and reduced Sh current in individual muscle fibers at the fly neuromuscular junction (NMJ). We thus concluded that loss of SSS or Sh leads to increased excitability. Since this effect is also accompanied by increased waking, we hypothesized that loss of qvr/sss or Sh leads to increased activity of wake-promoting neurons in the central brain. Loss of sleep in qvr/sss and Sh mutants cannot be attributed to seizure activity associated with hyperexcitability since such an effect would reduce locomotor activity, leading to an apparent increase in sleep, rather than the decrease actually observed for these animals. Loss of sleep in qvr/sss and Sh mutants also does not appear to be caused by hyperlocomotion associated with hyperexcitability since waking activity is unchanged in qvr/sss mutants [6] . To determine the role of qvr/sss-expressing neurons in control of the sleep/wake cycle more directly, we used the Gal4/UAS system [19] to express temperature-sensitive TRPA1 channels [20] in neurons that normally express qvr/sss [7] . By activating these neurons with a temperature pulse of 29 C for 6 hr from zeitgeber time (ZT)18-ZT24, sss-Gal4/UAS-TRPA1 animals were deprived of sleep relative to pulsed controls ( Figure 1A and Figure S1A available online). Thus, activation of qvr/sss-expressing neurons appears to be sufficient for waking.
In addition, we expressed temperature-sensitive shibire (shi ts ) in qvr/sss neurons under Gal4/UAS control. shi ts encodes a dominant mutant version of dynamin ATPase that blocks endocytosis and thus exocytosis at restrictive temperatures [21] . By raising the temperature of sss-Gal4/UAS-shi ts animals to 28 C for 6 hr from ZT0-ZT6, we found that sleep significantly increased in experimental animals compared to controls that lacked sss-Gal4 or shi ts expression (Figures 1B and S1B). This change is indeed sleep and not sickness or paralysis since experimental animals were able to right themselves within 10 s of being inverted during the temperature pulse (28/31, sss-Gal4>UAS-shi ts ; 32/32, sss-Gal4/+, 32/32, UAS-shi ts /+). Thus, activation of qvr/sss-expressing neurons also appears to be required for waking.
Pharmacological Antagonism of nAChR and Sh Activities Influences Sleep
We previously demonstrated that a reduction in either SSS or Sh causes a reciprocal reduction in the other protein [6, 7] . This observation is consistent with the idea that the two proteins can form a complex and mutually stabilize each other. These results led us to hypothesize that restoring the expression of Sh in qvr/sss mutants or vice versa using the Gal4/UAS system might rescue the severe sleep defects observed in both groups of animals. However, expression of UAS-Sh in sss P1 mutants or UAS-sss in Sh mns mutants under the control of sss-Gal4 was not sufficient to restore sleep to normal levels ( Figure S1C ), suggesting that additional factors might be required.
Interestingly, SSS is homologous to the endogenous nAChR antagonists lynx1 and lynx2, as well as to snake a-neurotoxins, some of which also affect acetylcholine signaling. Thus, we hypothesized that SSS might normally reduce nAChR activity in wake-promoting neurons to enable animals to sleep. According to this hypothesis, nAChR activity should be elevated in qvr/sss loss-of-function mutants, and perhaps in Sh mutants as well, since Sh upregulates SSS. To test this hypothesis, we fed WT, sss
P1
, and Sh mns flies increasing concentrations of the noncompetitive nAChR antagonist mecamylamine (MCA) and measured sleep 24-48 hr later. We found that treatment of WT animals with drug caused only a small increase in sleep. In contrast, treatment of both sss P1 and Sh mns mutants with MCA caused a dose-dependent restoration of sleep (Figures 1C and 1D ). We interpret these changes as true sleep rather than sickness or paralysis because the behavioral state was acutely reversible with brief mechanical agitation, and waking activity with drug treatment was as high as controls ( Figures S2A and S2B ). These findings strongly suggest that the ability of SSS and Sh to promote sleep under normal conditions is mediated in part by a suppression of nAChR activity and that loss of this suppression leads to reduced sleep in qvr/ sss and Sh mutants. This mechanism seems to be at least somewhat selective for qvr/sss and Sh mutants since mecamylamine was not able to increase sleep in Clk jrk mutants (Figure S3) , which have been reported to have low sleep [22] [23] [24] .
Although we previously reported that SSS enhances both Sh protein levels and gating kinetics, at that time we did not demonstrate a direct role for Sh in mediating the low-sleeping phenotype of qvr/sss mutants. To examine this relationship, (B) sss neurons are necessary for waking. sss-Gal4>UAS-shi ts , UAS-shi ts >+ and sss-Gal4>+ animals were heat pulsed to 28 C from ZT0-ZT6 from a baseline temperature of 22 C. Change in sleep was calculated as in (A), but over 12 hr (instead of 6) due to a heat-dependent shift in timing of daytime sleep. n > 15 animals for each group. we tested whether acute pharmacological inhibition of Sh activity in WT animals could reduce sleep, as observed in sss P1 and Sh mns mutants. To accomplish this task, we fed animals the voltage-gated potassium channel blocker 4-aminopyridine (4-AP). 4-AP treatment was able to dose-dependently reduce sleep in a WT background to levels similar to those observed in Sh mns mutants, but did not affect waking activity ( Figures 1E, 1F , and S2C). 4-AP appeared to act selectively on Sh rather than on other ion channels to reduce sleep since there was no effect of the drug on Sh mns mutants ( Figures  1E and 1F ). Tellingly, in transheterozygous sss P1 /sss P2 mutants in which sleep was reduced to levels equivalent to those observed in Sh mns mutants, 4-AP also had no acute effect. These results suggest that the reduced sleep in qvr/sss mutants is at least partially mediated by a reduction in Sh activity, which in turn leads to increased neuronal excitability in arousal-promoting neurons, as previously hypothesized [6, 7] .
qvr/sss Genetically Interacts with nAChR Subunits to Control Sleep
After determining that acute antagonism of nAChR activity could restore sleep to sss P1 mutants, we asked which nAChR subunits might be aberrantly upregulated in the absence of SSS. To address this question, we first determined which nAChR subunits are expressed in the adult fly brain. In mammals, nAChRs are homopentamers of alpha subunits or heteropentameters of alpha and beta subunits. In the fly genome, there are seven genes encoding alpha subunits (Da1-Da7) and three genes encoding beta subunits (Db1-Db3). The combinations of receptor subunits that can form functional channels in flies are unknown, largely because it has been difficult to measure activity of cloned fly nAChRs in heterologous expression systems [25] . Using quantitative PCR (qPCR) to measure the levels of nAChR transcripts, we found that all but one subunit is enriched in the adult fly brain relative to the body ( Figure S4A ).
To determine which of these subunits might be responsible for the increased waking time of qvr/sss mutants, we reduced expression of each alpha or beta subunit in sss-expressing neurons by RNAi knockdown. Consistent with our hypothesis that nAChR activity is upregulated in qvr/sss mutants, knockdown of Da3 in particular, and to a lesser extent Db3, partly restored sleep to sss P1 mutants (Figures 2A and 2B ) without affecting waking activity ( Figure S2D ), but had no effect on sleep in control animals with normal levels of qvr/sss expression ( Figure S4B ). qPCR analysis of Da3 transcripts from heads of panneuronal RNAi knockdown flies confirms an w65% reduction in Da3 expression levels ( Figure S4C ). These results suggest that excessive nAChR activity may be at least partly responsible for the increased waking time of sss P1 mutants. These results also indicate that nAChR activity does not normally need to be reduced by withdrawal of endogenous cholinergic signaling to allow WT animals to sleep.
To determine whether upregulation of nAChR activity in qvr/ sss-expressing neurons could reduce sleep, we coupled sssGal4 to a P element (d08339) inserted w40 bp upstream of the predicted transcriptional start site of the Da3 gene. Since this P element carries UAS sequences pointing in both directions along the X chromosome, animals bearing it in combination with sss-Gal4 should express elevated levels of Da3 transcript. When we tested these animals, we found that they expressed very high levels of Da3 mRNA and slept less than controls ( Figures S4D and 2C) . Thus, upregulation of Da3 nAChRs in qvr/sss-expressing neurons is sufficient to account for at least part of the low-sleeping phenotype of sss P1 mutants.
nAChRs Are Posttranscriptionally Regulated by SSS and Colocalize with SSS and Sh in the Mushroom Bodies
To determine whether SSS can indirectly regulate nAChRs by transcriptional feedback, we performed qPCR on Da3 and Db3, two of the nAChR subunits that genetically interacted with qvr/sss (Figures 2A and 2B ). Just as we previously showed for regulation of Sh transcript [7] , levels of fly brain nAChR transcripts are unchanged in sss P1 mutants. We also found that fly brain nAChR transcripts are similarly unchanged in Sh mns mutants ( Figure 3A) . Collectively, these data support a posttranscriptional role for regulation of nAChR activity by SSS, although we cannot exclude the possibility that upregulation of nAChR transcript in qvr/sss mutants occurs in a small subset of the neurons in our whole-brain preparations and is therefore undetectable in our assays.
If, however, SSS is acting directly on both K channels and nAChRs to suppress neuronal activity and promote sleep, then SSS and both effector proteins should be expressed in the same set of neurons. To determine whether this is indeed the case, we labeled qvr/sss-expressing neurons with UAS-tdTomato expressed under the control of sss-Gal4.
In the same brains, we also stained for the presence of Sh and Da3 using established antibodies for each molecule [7, 26] . We found overlapping expression of all three molecules in the mushroom bodies (MBs) ( Figure 3B ), which we and others previously showed to be important sleep-regulatory loci [27, 28] . Our cell labeling was likely to be specific for the intended antigens since Sh labeling disappeared in Sh mutants [7] , Da3 labeling was significantly reduced when antibody was preincubated with lysate from COS cells transfected with Da3 cDNA (Figures S5A-S5C) , and Da3 labeling increased in brains of animals in which sss-Gal4 was combined with UAS-Da3 (i.e., P element d08339) (Figure S5D) . Thus, the sleep-regulating proteins SSS, Sh, and Da3 are expressed together in a known sleep-regulating locus in the fly brain.
To determine whether the MBs might contribute to sleep regulation by qvr/sss, we first coupled the sss-Gal4 driver to UAS-sss in a sss P1 mutant background. As we previously demonstrated [7] , we found that the qvr/sss transgene was capable of fully rescuing the loss of sleep in sss P1 mutants. However, when we blocked expression of the qvr/sss transgene with MB-Gal80, a repressor of Gal4 activity that expresses in the MBs, restoration of sleep to otherwise genetically identical animals was reduced ( Figure 3C ). These data suggest that qvr/sss utilizes the MBs to regulate sleep, though they do not exclude the possibility that other brain regions may also be involved.
SSS Forms Stable Complexes with Both Sh and Da3
Our findings that SSS upregulates Sh and antagonizes nAChR activity in vivo suggest that SSS might mediate these effects directly. We previously demonstrated that SSS can form a complex with Sh channels in Xenopus oocytes, which express K currents very robustly after injection of Sh cRNA. To determine whether SSS can form complexes with Sh channels and with nAChRs in transfected cells, we first added a MYC epitope near the C terminus of SSS, just before the attachment site of glycosylphosphatidylinositol. We also fused GFP and hemagglutinin (HA) epitopes to the N and C termini of Sh and Da3, respectively. These constructs were expressed in HEKtsa cells, and complexes were immunoprecipitated with antibodies against either GFP (i.e., Sh) or HA (i.e., Da3). Subsequent western blot analyses revealed that SSS can be coimmunoprecipitated with Sh ( Figure 4A ) or Da3 ( Figure 4B ), but not in the absence of the channel or receptor ( Figures 4A   and 4B ). These results demonstrate that SSS can form stable complexes with both Sh and Da3.
SSS Reduces nAChR Activity
Regulation of Sh kinetics by SSS has previously been demonstrated in multiple expression systems [7, 8] . To determine whether complexes formed by SSS and nAChRs also result in altered receptor activity, we examined the contribution of SSS to nAChR function in transfected HEK-tsa cells. For these experiments, we used nAChRs from mice because fly nAChRs have been recalcitrant to functional expression on their own. In the absence of clear murine orthologs of fly nAChRs, we chose a4/b2 for our assay because these receptors express well in heterologous expression systems. In our assay, we measured agonist-dependent influx of Ca 2+ through receptors using the ratiometric fluorescence resonance energy transfer (FRET)-able cytosolic Ca 2+ reporter TN-XXL [29] . In the presence of a4/b2 and TN-XXL, the nicotinic agonist epibatidine elicited an increase in FRET ratio that was well fit by a sigmoidal concentration-response curve with a half-maximal effective concentration (EC 50 ) similar to previous reports [29] . In cells in which the qvr/sss cDNA was included in the transfection mixture, however, the maximal nAChR response was reduced by 75% ( Figures 4C and 4D) . Thus, in transfected cells, SSS suppresses nAChR function, just as in vivo. Taken together with our data showing that SSS and fly nAChRs can form a stable complex, these findings suggest that the functional suppression of nAChR activity by SSS is direct.
The Molecular Functions of SSS Homologs Are Conserved across Evolution SSS structurally resembles both snake a-neurotoxins such as a-bungarotoxin, which blocks nAChRs, and other ly6-domaincontaining proteins such as the endogenous mammalian nAChR antagonists lynx1 and lynx2. While SSS and lynx1 share only 18% amino acid identity, they both contain a series of conserved cysteines that are thought to form disulfide bonds that maintain the characteristic ''three-finger'' tertiary structure of the ly6 domain [7] . Thus, it is possible that the tertiary structures of SSS and lynx1 are similar enough that the two proteins could function interchangeably.
To test this hypothesis, we first performed coimmunoprecipitation experiments with MYC-tagged lynx1 and HA-tagged Da3 in transiently transfected HEK-tsa cells. Lynx1 is known to associate with mammalian nAChRs, and we found that like SSS, it could also form stable complexes with Da3 ( Figure 5A ). We further tested to see whether, like SSS, lynx1 was also able to associate with voltage-gated K channels. We fused GFP to the N terminus of Sh as well as its mammalian homolog, Kv1.2, and cotransfected cells with each construct along with the MYC-tagged lynx1 cDNA. In both cases we found that lynx1 could be coimmunoprecipitated with the K channel ( Figure 5B ). The formation of these complexes cannot be attributed to a tendency for lynx1 to associate with other proteins nonspecifically since lynx1 could not be coimmunoprecipitated with the membrane protein GRID2 (Figure 5B) . These results suggest that the targeting of voltagegated K channels and nAChRs by ly6 proteins is conserved across evolution.
On the basis of this conservation of molecular function, we tested whether lynx1 could replace SSS and allow flies to sleep normally. We generated UAS-lynx1 transgenic flies and expressed lynx1 under the control of sss-Gal4. Remarkably, we found that lynx1 can restore sleep to sss P1 mutants without altering waking activity ( Figures 5C and S2E) , demonstrating that lynx1 can function sufficiently like SSS to substitute for the latter in vivo.
Discussion
We previously demonstrated that SSS couples Sh levels and gating kinetics to reduced membrane excitability to allow sleep in Drosophila. Here we show that SSS interacts with and antagonizes nAChRs to promote sleep as well and that the activity of sss-expressing neurons is both necessary and sufficient for this process in Drosophila. The molecular bifunctionality of SSS is unexpected since K channels and nAChRs are functionally and structurally unrelated. For example, Shtype channels are gated by voltage, have six transmembrane domains and multimerize to form functional tetramers. In contrast, nAChRs are gated by synaptic release of acetylcholine, have four transmembrane domains and multimerize to form functional pentamers.
It is unclear which structural features SSS recognizes on each class of membrane protein, especially in the case of Sh, which is thought to expose little surface area outside the plasma membrane. X-ray structures of a-cobtratoxin (a-Cbtx) bound to Lymnaea stagnalis acetylcholine binding protein (LS-AChBP) show interactions between two loops of a-Cbtx and both the agonist binding pocket and the cis loop of AChBP [30] . Using this information and a nuclear magnetic resonance structure of water-soluble lynx1, Lyukmanova et al. modeled a possible interaction of lynx1 with the same site, although the loops of lynx1 were shorter than those of a-Cbtx and did not form as many contacts with the AChBP [31] .
It is also unclear whether such interactions, even if translated to SSS, would result in acute and direct antagonism of nAChR activity or, alternatively, reduction in targeting of receptors at the cell surface. Both potential mechanisms of action could account for the reduced a4/b2 activity we observed in cells transfected with qvr/sss. In addition, it is unknown whether a single SSS molecule can interact with both Sh and nAChRs simultaneously. However, our data suggest that all three proteins are coexpressed in some regions of the brain, particularly the mushroom bodies, which we and others have shown to play an important role in controlling sleep [27, 28, 32] . We previously showed that SSS is enriched in these structures, as well as in the antennal nerves, the superior protocerebrum, and the lobula plate of the optic lobes [7] , and here we show that MB-Gal80 reduces the ability of sss-Gal4>UAS-sss to restore sleep to sss P1 mutants. Nonetheless, the contribution of the MBs relative to other brain loci in regulating sleep via SSS, Sh, and Da3 still needs to be determined.
A particularly intriguing feature of SSS is its ability to reduce both membrane excitability and synaptic transmission, which endows the protein with unusual gain control over neuronal activity. In the present context, we propose that SSS reduces the activity of wake-promoting neurons through two pathways to permit sleep ( Figure 6 ). In one, it enhances Sh K channel protein levels and open channel probability to reduce neuronal excitability. In another pathway, it inhibits nAChR signaling to reduce synaptic transmission. In qvr/sss mutants the processes are reversed in wake-promoting neurons: K channel activity is reduced, leading to increased excitability, and nAChR activity is increased, leading to increased synaptic transmission. In these as well as Sh mutants, reduction of nAChR expression by RNAi knockdown or of nAChR activity by pharmacological antagonism reduces the activity of wakepromoting neurons within a range in which sleep can once again occur (Figure 6 ). Our finding that the molecular properties of SSS are shared by the mammalian homolog lynx1 suggests that ly6 proteins in general may have evolved a multitude of roles in regulating basic properties of the nervous system. It is notable that fundamental plastic processes are perturbed in loss-offunction mutants of qvr/sss and lynx1. For example, in sss P2 hypomorphs sleep homeostasis is impaired [6] , and in lynx1 knockouts the critical period for ocular dominance plasticity is extended to adulthood [17] . Although phenotypes have been described for additional ly6 mutants in both flies and mice, only in the case of SSS, lynx1 and lynx2 have molecular effectors been identified in vivo, and these are either K channels or nAChRs. Since over 20 ly6 genes have been described in Drosophila [14] and there appear to be many homologous genes in mammals, additional roles for these molecules may remain to be discovered.
In summary, we have identified a role for SSS in regulating synaptic transmission, in addition to its established role in regulating membrane excitability. Both functions appear to be important for the ability of SSS to regulate sleep in Drosophila. The ability of lynx1 to substitute for SSS and to form complexes with effectors of SSS, namely Sh-type K channels and nAChRs, suggests that lynx1 and perhaps other mammalian ly6 proteins possess similar, multifunctional roles in controlling neuronal activity. Potassium channels, nAChRs, and their modulators are key regulators or targets for molecular intervention in various human disorders, including ataxias, congenital deafness, epilepsy, cardiac arrhythmias, type II diabetes, autoimmune diseases such as multiple sclerosis and rheumatoid arthritis, cognitive decline in Alzheimer's disease, loss of motor coordination in Parkinson's disease, nicotine addiction and its associated risk of developing cancer, and cardiovascular disease from smoking [33] [34] [35] [36] [37] [38] [39] . Understanding the functions of ly6 proteins may provide insights into these disorders as well as new screening strategies for more selective and efficacious pharmacotherapeutic regulators of neuronal function.
Experimental Procedures Fly Stocks and Transgenic Fly Lines sss
P1
, sss-Gal4, and UAS-sss flies were described previously [6, 7] . Other lines were provided as follows: Sh mns (Chiara Cirelli), UAS-shi ts (Toshi Kitamoto), and UAS-TRPA1 (Paul Garrity). UAS-Da3 (stock d03389) was from the Exelixis collection at Harvard. 
Behavior Assays
One-to five-day-old flies were loaded into glass tubes containing 5% sucrose and 2% agarose and entrained to a 12 hr:12 hr light:dark (LD) cycle for 2 days before measurement of sleep/wake patterns using the Drosophila Activity Monitoring System (Trikinetics). Sleep was defined as 5 min of inactivity and was measured as previously described [22] . Experiments were carried out at 25 C except those involving 6 hr heat pulses to 27 C to activate TRPA1 or to 28 C to activate shi ts , in which case baseline temperature was maintained at 22
C. Prior to drug treatment, sucrose/agarose mixtures were equilibrated to 50 C, and the appropriate amounts of concentrated 4-AP (pH adjusted to 7.0; Acros Organics) or mecamylamine (R&D, Tocris) were added. Animals that had been entrained for 2 days on sucrose/agarose alone were switched to activity tubes containing the drug mixture at ZT0, and sleep was measured beginning 1 day later for a period of 24 hr. Animals that died within 4 days of drug intake were excluded from analysis.
Quantitative PCR For each sample, 30-50 brains or 7-12 heads from 5-to 9-day-old flies were lysed in Trizol (Life Technologies), and first-strand cDNA was synthesized from extracted RNA using High Capacity cDNA Reverse Transcription (ABI). qPCR was performed on each cDNA sample using the primers listed in the Table S1 , and results were normalized to levels measured for RP49. Relative expression was further normalized to brain Da1 levels (Figure S4A ) or levels of Da3 or Db3 transcript measured in w 1118 controls (Figure 3) . All primer pairs were validated for amplification efficiencies (R 2 ) greater than 0.98.
Molecular Biology
For generation of GFP-tagged Shaker, eGFP was amplified from eGFP-C3 (Clontech) by PCR using Hind-eGFP-F and eGFP-Xho-R primers (Table  S2 ) and subcloned in frame at the 5 0 end of ShD in pcDNA3 [7] using HindIII and XhoI. GFP-tagged Kv1.2 was generated by replacement of ShD with Kv1.2 that had been amplified by PCR with Xho-Kcna2-F and Kcna2-Not-R2 primers (Table S2 ) and cut with XhoI-NotI. GFP-GRID2 was similarly generated by amplification of eGFP with EcoR1-eGFP-F and eGFP-Kpn1-R primers (Table S2 ) and subcloning of the fragment into the EcoRI and KpnI sites of Flag-GRID2 (a kind gift from Z. Yue, Mt. Sinai).
For generation of Myc-tagged SSS, EcoRV and Xho1 sites were first inserted into sss in pcDNA3 [7] by PCR using SSS-Cmyc-S and SSS-Cmyc-AS primers (Table S2) . Cmyc-S and Cmyc-AS oligos encoding the Myc epitope (Table S2) were then annealed and subcloned into the newly engineered EcoRV and Xho1 sites. For generation of Myc-tagged lynx1, an EST (I.M.A.G.E. ID 5325123, Open Biosystems) encoding full-length mouse lynx1 was first amplified by PCR with primers EcoR1-Lynx1-F and Lynx1-Not1-R (Table S2 ) and subcloned between the EcoRI and NotI sites of pcDNA3. A fragment of Myc-tagged SSS was then amplified by PCR with the primers Lynx1-Myc-F and Lynx1-Myc-R (Table S2) , and the resulting product was used for primer extension using lynx1 in pcDNA3 as a template. The product of this reaction was then amplified with EcoR1-Lynx1-F and Lynx1-Not1-R primers (Table S2 ) and subcloned between the EcoR1 and Not1 sites of pcDNA3.
To generate HA-tagged Da3, we first subcloned oligos Not1-HA-Xba1-S and Not1-HA-Xba1-AS (Table S2) between the NotI and XbaI sites of pcDNA3 to make pcDNA3-HA. For fusion of Da3 to the HA epitope, Da3 was amplified by PCR from an EST (DGRC clone number 12624) using primers Da3-Kpn1-F and Da3-Not-R (Table S2 ) and subcloned into the KpnI and NotI sites of pcDNA3-HA.
UAS-lynx1 was generated by subcloning of the previously described fulllength mouse EST into pUAST-attB between the EcoRI and NotI sites.
Immunohistochemistry Three-to seven-day-old female brains were dissected in ice-cold PBS before fixation in 4% paraformaldehyde. Brains were blocked in PBST (PBS and 0.3% Triton X-100) containing 5% normal donkey serum (Jackson Laboratory) and 5% normal goat serum (Life Technologies). Brains were incubated with 1:200 rat anti-Sh [40] precleared with Sh Df lysate followed sequentially by incubation with 1:250 rabbit anti-Da3 bleed 88 [26] . Brains were washed with PBST and stained with 1:1000 Alexa 633 antirabbit (Life Technologies) and 1:1,000 anti-rat Alexa 488 (Jackson ImmunoResearch). After additional washes, brains were equilibrated and mounted in Vectashield (Vector Labs). Images were taken at 403 magnification on a Leica SP5 confocal microscope using 0.5 mm stack intervals. Z projection images (5 mm) were generated and rotated, and brightness/contrast adjustments were made across the entirety of the images using Fiji [41] .
Cell Culture and Coimmunoprecipitations
Cos-7 and HEK-tsa cells were maintained at 25 C and 7.5% CO 2 in culture medium consisting of 10% fetal bovine serum (Omega), 1% penicillin/ streptomycin (Mediatech), and 1% L-glutamine (Sigma) in low-glucose Dulbecco's modified Eagle's medium with 2 mM L-Glutamine (Mediatech). Cells were grown to 50%-80% confluence for transfection with X-tremegene HP reagent (Roche) at a 2:1 ratio of transfection reagent to DNA in Optimem (Life Technologies). Transfection mixture was removed 24 hr after transfection and replaced with normal growth medium. Cells were lysed 48 hr after transfection in SDS lysis/immunoprecipitation (IP) buffer (10 mM Tris [pH 7.5], 100 mM NaCl, 5mM EDTA, 1% Triton X-100, and 0.05% SDS) with complete protease inhibitors (Roche). For coimmunoprecipitation assays, 500 mg of total cell lysate was incubated in a total volume of 1 ml SDS lysis/IP buffer with primary antibodies overnight at 4 C on a rotating platform. The following day, protein-G-conjugated magnetic beads (NEB) were added and incubated at 4 C for 2-5 hr. Beads were washed three times in a 1 ml volume of IP wash buffer (10 mM Tris [pH 7.5], 100 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, and 0.05% SDS) and resuspended in 23 LDS sample buffer (Life Technologies). Antibodies used were rabbit anti-GFP (Life Technologies) or rabbit anti-HA (Rockland).
Western Blot Analyses
Western blot analyses of Cos-7 cell lysates and coimmunoprecipitation complexes were performed as previously described [40] . For 20% input conditions, 100 mg of protein was loaded per lane. Proteins were detected using the following antibodies: rabbit anti-GFP (Life Technologies), mouse anti-HA (Covance), mouse anti-Myc (Santa Cruz Biotechnologies), and mouse anti-actin (Millipore EMD).
FRET-Based Measurements of nAChR Activity
Measurements of a4b2 nAChR activity were performed as previously described [29] with the following alterations: HEK-tsa cells were transiently transfected with a4-pciNeo and b2-dm-pciNeo (gifts from H. Lester) plus TN-XXL (gift from P. Taylor) supplemented with either sss-pcDNA3 or pcDNA3 alone at a ratio of 1:1:2:10, respectively. Cells were preincubated in growth media containing 1 mM nicotine (R&D, Tocris) for 20 hr prior to assay in artificial cerebral spinal fluid (ACSF; 121 mM NaCl, 5 mM KCl, 26 mM NaHCO 3 SSS reduces neuronal activity in arousal-promoting neurons through two pathways to permit sleep. SSS enhances Sh K channel activity to reduce intrinsic excitability (left). SSS also suppresses nAChR activity to reduce synaptic transmission (right). Pharmacological or genetic antagonism of nAChR activity functionally substitutes for SSS to restore sleep to sss P1 mutants (right). The bidirectional arrow (left) reflects mutual dependence of Sh and SSS for elevated expression levels of both proteins.
